University leads research towards regenerative therapies for kidney disease
The University of Liverpool will be leading a European research project, together with 14 partners, to develop new devices and methods for diagnosing kidney disease.
The University of Liverpool (UK) will be coordinating a new €4.1 million research project, named ‘RenalToolBox’, together with 14 partners, that aims to develop new therapies to delay the progression of end-stage kidney disease. If successful, these therapies have the potential to extend treatment choices for patients suffering from chronic kidney disease, whose current options are a kidney transplant or dialysis.
The project will investigate the use of mesenchymal stromal cells as new therapies as they have shown promise in preclinical studies and are already used in the clinic for degenerative and autoimmune diseases. In particular, research will aim to understand the mechanism of action for tissue repair and regeneration, potential risk factors, and ideal patients to receive the treatment.
Project coordinator, Patricia Murray, the University of Liverpool, commented “This exciting research project will provide the appointed students with the required knowledge, skills and state-of-the-art technologies needed to investigate the true potential of renal regenerative medicine therapies.”